Literature DB >> 11026559

Immunohistochemical distribution of chicken ovalbumin upstream promoter transcription factor II in human tissues.

T Suzuki1, T Moriya, A D Darnel, J Takeyama, H Sasano.   

Abstract

Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is an orphan member of the steroid/thyroid hormone receptor superfamily. The present study examines the immunohistochemical distribution of COUP-TFII in human adult tissues. In the reproductive and endocrine systems, COUP-TFII immunoreactivity was detected in the stroma, vascular endothelium and smooth muscle, while it was less frequent in adrenal 4 binding protein (Ad4BP) positive steroidogenic cells. In lung, COUP-TFII immunoreactivity was detected in the vascular endothelium of alveolar septae. In kidney, the glomerular endothelium and Bowman's capsule were immunopositive for COUP-TFII. COUP-TFII immunoreactivity in the gastro-intestinal tract, liver and spleen were detected in mesenchymal cells, sinusoid endothelium and reticuloendothelium, respectively. Results from this study demonstrated the detection of COUP-TFII immunoreactivity in all human tissues examined, especially in mesenchymal cells. The widespread expression of COUP-TFII suggests that COUP-TFII may play an important role in the function and homeostasis of various human tissues and organs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11026559     DOI: 10.1016/s0303-7207(00)00242-2

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

Review 1.  Nuclear receptors and pathogenesis of pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

2.  Expression of the hepatic specific V1 messenger ribonucleic acid of the human growth hormone receptor gene is regulated by hepatic nuclear factor (HNF)-4alpha2 and HNF-4alpha8.

Authors:  Cynthia Gates Goodyer; Zakaria Rhani; Hong Zheng
Journal:  Mol Endocrinol       Date:  2007-11-08

3.  Involvement of transcription factor NR2F2 in human trophoblast differentiation.

Authors:  Michael A Hubert; Susan L Sherritt; Cindy J Bachurski; Stuart Handwerger
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 4.  Multiple roles of COUP-TFII in cancer initiation and progression.

Authors:  Lacey M Litchfield; Carolyn M Klinge
Journal:  J Mol Endocrinol       Date:  2012-10-10       Impact factor: 5.098

5.  Expression and functional pathway analysis of nuclear receptor NR2F2 in ovarian cancer.

Authors:  Shannon M Hawkins; Holli A Loomans; Ying-Wooi Wan; Triparna Ghosh-Choudhury; Donna Coffey; Weimin Xiao; Zhandong Liu; Haleh Sangi-Haghpeykar; Matthew L Anderson
Journal:  J Clin Endocrinol Metab       Date:  2013-05-20       Impact factor: 5.958

Review 6.  Regulatory potential of COUP-TFs in development: stem/progenitor cells.

Authors:  Xin Xie; Ke Tang; Cheng-Tai Yu; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Semin Cell Dev Biol       Date:  2013-08-23       Impact factor: 7.727

7.  Chicken ovalbumin upstream promoter transcription factor II regulates uncoupling protein 3 gene transcription in Phodopus sungorus.

Authors:  Tobias Fromme; Kathrin Reichwald; Matthias Platzer; Xing-Sheng Li; Martin Klingenspor
Journal:  BMC Mol Biol       Date:  2007-01-04       Impact factor: 2.946

8.  Regulation of the orphan nuclear receptor Nr2f2 by the DFNA15 deafness gene Pou4f3.

Authors:  Chrysostomos Tornari; Emily R Towers; Jonathan E Gale; Sally J Dawson
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

9.  Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development.

Authors:  Hui-Ju Lee; Chung-Yang Kao; Shih-Chieh Lin; Mafei Xu; Xin Xie; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

10.  NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.

Authors:  Baili Xia; Lijun Hou; Huan Kang; Wenhui Chang; Yi Liu; Yanli Zhang; Yi Ding
Journal:  BMC Cancer       Date:  2020-07-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.